Changes in [3H]5-HT uptake and [3H]imipramine binding in platelets after chlorimipramine in healthy volunteers. Comparison with maprotiline and amineptine.

No abstract is available for this paper.

• Publication year

  1987

• Venue

  Biological Psychiatry

• Publication date

  1987-03-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/0006-3223(87)90147-8PMID 3028514
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Reduced Bmax of [3H]-imipramine binding to platelets of depressed patients free of previous medication with 5HT uptake inhibitors

  2006cited by this paper
• Increased platelet serotonin in bipolar depression and hypomania

  2005cited by this paper
• Inhibitors of serotonin and noradrenaline uptake in human plasma after withdrawal of zimelidine and clomipramine treatment

  2004cited by this paper
• Platelet 3H-imipramine binding and steroid hormones serum concentrations during the menstrual cycle

  2004cited by this paper
• Inhibition of 5-hydroxytryptamine uptake in human platelets by antidepressant agents in vivo

  2004cited by this paper
• Changes in human platelet 5 HT level after 1 week of chlorimipramine treatment

  2004cited by this paper
• High-affinity 3H-imipramine binding in platelets from untreated and treated depressed patients compared to healthy volunteers

  2004cited by this paper
• Increased uptake of serotonin by blood platelets from patients with bipolar primary affective disorder-bipolar type

  2004cited by this paper
• Temperature Dependence of Drug Interaction with the Platelet 5‐Hydroxytryptamine Transporter: A Clue to the Imipramine Selectivity Paradox

  1987cited by this paper
• Lack of seasonal variation in platelet [3H]imipramine binding in humans.

  1986cited by this paper
• Serotonin uptake inhibitors differentially modulate high affinity imipramine dissociation in human platelet membranes.

  1985cited by this paper
• Imipramine treatment differentially affects platelet 3H-imipramine binding and serotonin uptake in depressed patients.

  1985cited by this paper
• Tryptamine, a Substrate for the Serotonin Transporter in Human Platelets, Modifies the Dissociation Kinetics of [3H]Imipramine Binding: Possible Allosteric Interaction

  1985cited by this paper
• Tritiated imipramine binding distinguishes among subtypes of depression.

  1985cited by this paper
• 3H-Imipramine binding sites in platelets of hospitalized psychiatric patients.

  1985cited by this paper
• Unchanged platelet 3H-imipramine binding in normal subjects after imipramine administration.

  1985cited by this paper
• The dexamethasone suppression test in panic disorder: comparison with normal controls.

  1985cited by this paper
• 5‐Methoxytryptoline, a Competitive Endocoid Acting at [3H]Imipramine Recognition Sites in Human Platelets

  1985cited by this paper
• High-performance liquid chromatographic method for the determination of amineptine and its main metabolite in human plasma.

  1984cited by this paper
• Saturable uptake of [3H]-tryptamine in rabbit platelets is inhibited by 5-hydroxytryptamine uptake blockers

  1984cited by this paper
• [3H]Imipramine binding and [3H]5HT uptake in human blood platelets: changes after one week chlorimipramine treatment.

  1984cited by this paper
• Reduced Vmax of 3H-serotonin uptake but unchanged 3H-imipramine binding in the platelets of untreated hypertensive subjects.

  1984cited by this paper
• Changes in the binding to platelets of [3H]imipramine and [3H]yohimbine in normal subjects taking amitriptyline.

  1984cited by this paper
• Seasonal variation in platelet 3H-imipramine binding: comparable values in control and depressed populations.

  1984cited by this paper
• Possible endocrine role of the pineal gland for 6-methoxytetrahydro-beta-carboline, a putative endogenous neuromodulator of the [3H]imipramine recognition site.

  1984cited by this paper
• Substituted tetrahydro-beta-carbolines are possible candidates as endogenous ligand of the [3H]imipramine recognition site.

  1984cited by this paper
• High affinity 3H-imipramine binding in human platelets: age and sex effects.

  1984cited by this paper
• Complex Inhibition of [3H]Imipramine Binding by Serotonin and Nontricyclic Serotonin Uptake Blockers

  1983cited by this paper
• Circannual variations in the density of tritiated imipramine binding sites on blood platelets in man.

  1983cited by this paper
• 3H-imipramine platelet binding sites in unipolar depression.

  1983cited by this paper
• 3H-imipramine binding sites in platelets from psychiatric patients.

  1982cited by this paper
• [Plasma assay of clomipramine and demethylclomipramine by high performance liquid chromatography].

  1982cited by this paper
• Platelet 3H-imipramine binding in euthymic bipolar patients.

  1982cited by this paper
• High-affinity binding of 3H-imipramine in brain and platelets and its relevance to the biochemistry of affective disorders.

  1981cited by this paper
• Depressed patients have decreased binding of tritiated imipramine to platelet serotonin "transporter".

  1981cited by this paper
• Quantitative high-performance liquid chromatographic assay for the determination of maprotiline and oxaprotiline in human plasma.

  1981cited by this paper
• Reduced uptake of serotonin but unchanged 3H-imipramine binding in the platelets from cirrhotic patients.

  1981cited by this paper
• High-affinity [3H]imipramine binding in rat hypothalamus: association with uptake of serotonin but not of norepinephrine.

  1980cited by this paper
• Long-term effect of lithium on the uptake of 5-hydroxytryptamine by human platelets.

  1980cited by this paper
• Specific 3H-imipramine binding in human platelets

  1980cited by this paper
• Decreased 3H-imipramine binding in depressed males and females.

  1980cited by this paper
• Seasonality in biochemical determinations: a source of variance and a clue to the temporal incidence of affective illness.

  1979cited by this paper
• Chronic treatment with clomipramine or maprotiline depletes platelet serotonin and modifies its diurnal rhythm

  1978cited by this paper
• Platelet 5-hydroxytryptamine accumulation in depressive illness.

  1978cited by this paper
• Biochemical and pharmacological studies on amineptine (S 1694) and (+)‐amphetamine in the rat

  1977cited by this paper
• Comparison of the effects of maprotiline (ludiomil) and clomipramine (anafranil) on serotonin uptake and tryptophan-binding in plasma.

  1976cited by this paper
• Decreased uptake of 5-hydroxytryptamine in blood platelets from depressed patients

  1976cited by this paper

• Sex differences in diencephalon serotonin transporter availability in major depression.

  2006cites this paper
• Platelet 5-HT uptake sites in depression: three concurrent measures using [3H] imipramine and [3H] paroxetine

  2005cites this paper
• Increased plasma free serotonin but unchanged platelet serotonin in bipolar patients treated chronically with lithium

  2004cites this paper
• Long-term effects of tricyclic antidepressants on norepinephrine kinetics in humans

  2001cites this paper
• The cortical serotonin2 receptors studied with positron-emission tomography and [18F]-setoperone during depressive illness and antidepressant treatment with clomipramine.

  1999cites this paper
• Chronic clomipramine and triiodothyronine increase serotonin levels in rat frontal cortex in vivo: relationship to serotonin autoreceptor activity.

  1999cites this paper
• Differential changes in brain and platelet 5-HT concentrations after steady-state achievement and repeated administration of antidepressant drugs in mice.

  1999cites this paper
• Plasma melatonin and cortisol in patients with obsessive-compulsive disorder: relationship with axillary temperature, physical activity, and clinical symptoms.

  1998cites this paper
• Effect of fluvoxamine on platelet 5-HT2A receptors as studied by [3H]lysergic acid diethylamide ([3H]LSD) binding in healthy volunteers

  1997cites this paper
• Platelet serotonergic indices in major depression: up-regulation of 5-HT2A receptors unchanged by antidepressant treatment.

  1997cites this paper
• Use of selective serotonin reuptake inhibitors and other serotonergic drugs in the biological dissection of affective disorders

  1995cites this paper
• Biological markers of serotonin receptors in depression and animal models of depression

  1995cites this paper
• Lack of association between platelet tritiated imipramine binding and clinical status of depressed patients on chronic antidepressant treatment.

  1994cites this paper
• Is platelet imipramine binding reduced in depression? A meta-analysis.

  1994cites this paper
• Biochemical Strategies for the Development of Antidepressants

  1994cites this paper
• A single electroconvulsive treatment affects platelet serotonin uptake in bipolar I patients.

  1993cites this paper
• Mianserin-induced up-regulation of serotonin receptors on normal human platelets in vivo.

  1993cites this paper
• Peripheral markers in anxiety and depression.

  1992cites this paper
• Effects of acute and chronic treatment with fluvoxamine on extracellular and platelet serotonin in the blood of major depressive patients. Relationship to clinical improvement.

  1992cites this paper
• Platelet 3H‐imipramine binding during recovery from depression

  1992cites this paper
• [Nonspecific factors and variations in biological parameters studied in biological psychiatry].

  1992cites this paper
• Rapid changes in 3H‐imipramine platelet binding after chronic treatment with amineptine, a selective dopamine uptake blocker, in major depressed patients

  1992cites this paper
• Effects of monoamine uptake inhibitors on extracellular and platelet 5‐hydroxytryptamine in rat blood: different effects of clomipramine and fluoxetine

  1992cites this paper
• Drug washout issues in studies of cerebral metabolism by positron emission tomography in psychiatric patients.

  1992cites this paper
• Effect of Antidepressants on Neurotransmission: a Common Mechanism of Action?

  1992cites this paper
• PERIPHERAL MARKERS IN AFFECTIVE DISORDERS

  1991cites this paper
• Platelet [3H]imipramine and alpha 2-adrenoceptor binding in normal subjects during desipramine administration and withdrawal.

  1991cites this paper
• Platelet 3H-imipramine binding in major depressive episodes

  1991cites this paper
• Differential effects of clomipramine given locally or systemically on extracellular 5-hydroxytryptamine in raphe nuclei and frontal cortex

  1991cites this paper
• Differential effects of clomipramine given locally or systemically on extracellular 5-hydroxytryptamine in raphe nuclei and frontal cortex. An in vivo brain microdialysis study.

  1991cites this paper
• Effects of clomipramine treatment on cerebrospinal fluid monoamine metabolites and platelet 3 H‐imipramine binding and serotonin uptake and concentration in major depressive disorder

  1991cites this paper
• Tritiated imipramine binding in obsessive-compulsive volunteers and psychiatrically normal controls.

  1990cites this paper
• Lithium treatment effect on serotonin function.

  1990cites this paper
• Platelet imipramine binding in children and adolescents with impulsive behavior.

  1990cites this paper
• Validity of Imipramine Platelet Binding Sites as a Biological Marker of Endogenous Depression

  1990cites this paper
• Platelet imipramine binding in endogenous depressed patients and controls: relationship to platelet MAO and 5HT uptake during successful imipramine treatment.

  1990cites this paper
• 3H-Imipramine Binding to Previously Frozen Platelet Membranes from Depressed Patients, Before and After Treatment

  1990cites this paper
• Effects of fluoxetine treatment of platelet 3H-imipramine binding, 5-HT uptake and 5-HT content in major depressive disorder.

  1990cites this paper
• Changes in platelet 3H-imipramine binding with chronic imipramine treatment are not state-dependent.

  1989cites this paper
• Clinical Pharmacology in Psychiatry

  1989cites this paper
• Evaluation of clinical and biological parameters in healthy volunteers: more than pharmacokinetics and side effects?

  1989cites this paper
• Platelet 3H-imipramine binding sites in depressed patients and healthy controls: a comparison between morning and afternoon samples.

  1989cites this paper
• Light-dark differences in [3H]-paroxetine binding to rabbit platelet membranes

  1989cites this paper
• 3H-imipramine binding to freshly prepared platelet membranes in depression.

  1989cites this paper
• Imipramine binding in depressive patients diagnosed according to different criteria

  1988cites this paper
• Effects of antidepressants on monoamine transporters.

  1988cites this paper
• Studies on the serotonin transporter in platelets

  1988cites this paper
• Up-regulatory effect of triphasic oral contraceptive on platelet 3H-imipramine binding sites.

  1988cites this paper
• Circadian rhythm of the Bmax of [3H]-imipramine binding in rabbit platelets

  1987cites this paper
• Association of [3H]-imipramine and [3H]-paroxetine binding with the 5HT transporter in brain and platelets: relevance to studies in depression.

  1987cites this paper